What Does the Evidence Actually Say About HRT?

The Most Misunderstood Treatment in Women's Health

For women under 60 or within 10 years of menopause onset, the current evidence supports HRT as a safe and effective treatment for perimenopausal symptoms. It's the most effective option for hot flushes, night sweats, sleep disruption, and cognitive symptoms. The breast cancer risk from HRT is small and comparable to other common lifestyle factors. Individual risk assessment matters - some women can't take HRT due to personal or family history, but most symptomatic women are candidates.

No topic in midlife women's health generates more confusion than hormone replacement therapy. Decades of conflicting headlines, a pivotal study that was later reinterpreted, and persistent myths have left millions of women either afraid of a treatment that could help them or unable to access it. Here's what the current evidence actually says  - clearly, without spin.

What HRT Does

HRT replaces the hormones - primarily oestrogen and, where needed, progesterone - that your body produces less of during perimenopause and menopause. By restoring these hormones to physiological levels, HRT addresses the root cause of menopausal symptoms rather than managing them individually.

The evidence for symptom relief is strong. HRT is the most effective treatment for hot flushes and night sweats, reducing them by approximately 75% in most women. It improves sleep quality, reduces anxiety and mood disturbance, and can significantly improve cognitive symptoms including brain fog.

Beyond Symptom Relief

HRT's benefits extend beyond the symptoms you feel. Oestrogen replacement supports bone density, reducing fracture risk. It has a protective effect on cardiovascular health when started within 10 years of menopause onset (the "window of opportunity"). It supports vaginal and urogenital health, reducing the risk of recurrent urinary tract infections and addressing vaginal dryness. And emerging research suggests potential neuroprotective effects, though this area is still developing.

What Does the Evidence Actually Say About HRT and Breast Cancer Risk?

The 2002 Women's Health Initiative (WHI) study triggered widespread fear about HRT, particularly regarding breast cancer risk. Subsequent reanalysis of that data - and extensive further research - has provided a more nuanced picture.

For women starting HRT before age 60 or within 10 years of menopause, the benefits generally outweigh the risks. The breast cancer risk associated with combined HRT (oestrogen plus progestogen) is small - comparable to the risk associated with drinking two glasses of wine daily or being obese. Oestrogen-only HRT (for women who have had a hysterectomy) shows no increased breast cancer risk in most studies, and some show a reduced risk.

Body-identical hormones - oestradiol and micronised progesterone - have a more favourable risk profile than the older synthetic hormones used in the WHI study. Transdermal oestrogen (patches or gel) carries no increased risk of blood clots, unlike oral preparations.

Types of HRT

HRT is not one-size-fits-all. Oestrogen can be delivered transdermally (patches, gel, spray) or orally. Progesterone can be given as micronised progesterone (body-identical) or as a synthetic progestogen. Testosterone can be added where indicated - for libido, energy, and cognitive function. The combination, dosage, and delivery method should be tailored to the individual woman's symptoms, risk factors, and preferences.

Is HRT Safe for You? How Do You Actually Decide?

Most women with perimenopausal or menopausal symptoms are candidates for HRT. Contraindications exist - primarily a history of hormone-receptor-positive breast cancer, active blood clots, or certain liver conditions. For women with these histories, alternatives exist and should be discussed with a specialist.

For the majority of symptomatic women, the evidence supports informed, personalised use of HRT as a safe and effective treatment. This is the position of NICE, the British Menopause Society, the International Menopause Society, and the North American Menopause Society.

The Decision Is Yours

HRT is not for everyone. But the decision should be based on current evidence and individual risk assessment - not on fear generated by outdated headlines. You deserve a clear, honest conversation with a knowledgeable provider. If you're not getting one, seek a second opinion. This decision is too important to make in the dark.

The Individual Response Heterogeneity That Makes "Standard" Advice Misleading

HRT outcomes vary substantially between individuals based on genetics, the specific formulation and dose, route of administration, timing of treatment, and individual symptom profile. Some women feel dramatically better within weeks. Others need months to see benefit. Some respond well to oral HRT; others need transdermal (patch) administration for better outcomes. Some benefit from oestrogen alone; others need the addition of progesterone or other compounds. This heterogeneity is why population studies show modest average benefit - because the benefits and risks are distributed differently across individuals.

For a woman whose symptoms are severely disrupting sleep, cognition, and quality of life, HRT often produces dramatic improvement. For a woman with mild symptoms, the benefit-to-risk calculation is different. For a woman with personal or family history of breast cancer, the risk profile shifts. These individual factors matter more than the headline findings from large trials.

The Informed Decision Framework That Includes Personal Risk Assessment

Rather than a blanket "HRT yes" or "HRT no" position, the current evidence supports an informed decision approach. Understand the actual risks (substantially lower than previously believed, but not zero). Understand the benefits (substantial for symptom relief, some benefit for bone health and cognitive function, variable benefit for cardiovascular health based on timing and individual factors). Know your personal risk factors (age, family history, smoking status, individual medical history). Discuss options with a provider knowledgeable about HRT. Make a decision based on your personal risk-benefit calculation, not on ideological position. This approach - individualised, evidence-based, informed - is what appropriate medicine looks like.

Frequently Asked Questions

How long does HRT take to work?

Most women see improvement in hot flushes and night sweats within 2-4 weeks. Sleep quality often improves within this window too. Cognitive symptoms like brain fog can take 4-8 weeks to improve. The timeline varies - some women see change within days, others need months of adjustment to find the right formulation and dose.

What's the difference between body-identical HRT and other types?

Body-identical hormones - oestradiol and micronised progesterone - match what your body naturally produces. Synthetic hormones used in older HRT formulations have different molecular structures. Body-identical hormones have a more favourable safety profile and often feel better to women in practice. This distinction matters when choosing an HRT regimen.

Do you need HRT forever?

No. Some women take HRT for a few years during their most symptomatic phase and then gradually reduce and stop. Others take it longer. The decision is individualised based on symptom severity, personal risk factors, and how you respond. Periodic review with your healthcare provider helps determine the right duration for you.

What if you have a family history of breast cancer?

Family history doesn't automatically exclude HRT, but it requires more detailed risk assessment. Some types of family history (early-onset breast cancer, or multiple relatives affected) change the risk calculation. Discuss your specific family history with a specialist menopause provider who can help you weigh the actual risks against the substantial symptom relief HRT typically provides.